by admin | Feb 16, 2016 | Archive
February 16, 2016 CVS Pharmacy has agreed to pay $8 million to the United States to resolve claims that its pharmacies in Maryland violated the Controlled Substances Act (CSA) by dispensing controlled substances pursuant to prescriptions that were not issued for a... by admin | Feb 16, 2016 | Archive
February 16, 2016 A new study shows an association between proton pump inhibitors (PPIs) and an increased risk of dementia among older adults. German researchers conducted a prospective cohort study using observational data on more than 73,600 patients from 2004–11.... by admin | Feb 16, 2016 | Archive
February 16, 2016 Express Scripts officials say they are carefully scrutinizing prescriptions for products made by Valeant Pharmaceuticals International, making sure the PBM’s rules are being followed. “We are looking at every single claim for their... by admin | Feb 16, 2016 | Archive
February 16, 2016 Glucagon-like peptide 1 (GLP-1) analogues are licensed for type 2 diabetes, but they could also be effective in treating patients with non-alcoholic steatohepatitis. To test this, researchers injected the long-acting GLP-1 analogue liraglutide into... by admin | Feb 16, 2016 | Archive
February 16, 2016 Under revised language proposed by FDA, companies no longer have to “provide adequate labeling” for non-FDA-approved uses of their products that they know about. Patient advocates worry that companies will use the new rule to avoid liability for... by admin | Feb 16, 2016 | Archive
February 16, 2016 CVS Pharmacy has agreed to pay $8 million to the United States to resolve claims that its pharmacies in Maryland violated the Controlled Substances Act (CSA) by dispensing controlled substances pursuant to prescriptions that were not issued for a...